roxadustat

AstraZeneca finally drops roxadustat US rights after FDA rejection, trial failure
Fierce Pharma
Tue, 02/27/24 - 11:16 am
AstraZeneca
FibroGen
roxadustat
anemia
FibroGen’s anemia pill falls short in blood cancer study
BioPharma Dive
Sun, 05/7/23 - 10:18 pm
FibroGen
bone marrow
clinical trials
roxadustat
After high-profile US rejection for roxadustat, Astellas touts its safety in new pooled analysis
Fierce Pharma
Thu, 05/19/22 - 10:32 am
Astellas
roxadustat
FibroGen
ERA
erythropoietin
AstraZeneca, FibroGen can't agree on roxadustat's path forward in chronic kidney disease after FDA rejection
Fierce Pharma
Tue, 05/10/22 - 10:40 am
AstraZeneca
FibroGen
chronic kidney disease
roxadustat
AstraZeneca, FibroGen hope to keep their roxadustat dream alive with new FDA meeting
Fierce Pharma
Wed, 11/10/21 - 10:42 am
FibroGen
AstraZeneca
anemia
roxadustat
FDA
Astellas readies roxadustat for launch
EP Vantage
Wed, 09/15/21 - 10:37 am
Astellas
roxadustat
drug launches
FibroGen, fresh off data manipulation scandal, touts win in cancer patients without revealing data
Endpoints
Wed, 08/25/21 - 11:20 am
FibroGen
roxadustat
cancer
anemia
clinical trials
data manipulation
FDA declines to approve FibroGen's anemia drug
Yahoo/Reuters
Wed, 08/11/21 - 12:07 pm
FibroGen
FDA
anemia
chronic kidney disease
roxadustat
FibroGen slides after FDA posted documents ahead of AdCom meeting on Roxadustat
Seeking Alpha
Tue, 07/13/21 - 11:06 am
FibroGen
FDA
roxadustat
advisory panels
chronic kidney disease
FibroGen shares take a beating as CEO reveals safety data manipulation for its blockbuster contender roxadustat
Endpoints
Tue, 04/6/21 - 11:13 pm
FibroGen
anemia
roxadustat
FibroGen shares skid lower as a surprise adcomm raises risks on roxa OK
Endpoints
Tue, 03/2/21 - 10:59 am
FibroGen
roxadustat
FDA
advisory panel
AstraZeneca, FibroGen's roxadustat hits snag at FDA, but analysts figure an approval's still on its way
Fierce Pharma
Mon, 12/21/20 - 11:46 pm
AstraZeneca
FibroGen
roxadustat
FDA
anemia
FibroGen Provides More Support for Roxadustat in Anemia Associated with Kidney Disease
BioSpace
Mon, 10/26/20 - 11:15 pm
FibroGen
roxadustat
ASN
chronic kidney disease
5 FDA approval decisions to watch in the 4th quarter
BioPharma Dive
Wed, 09/30/20 - 10:45 am
FDA
drug approvals
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Regeneron
EB3
ebola virus
Alkermes
ALKS-3831
schizophrenia
bipolar disorder
Bristol-Myers Squibb
liso-cel
non-Hodgkin lymphoma
roxadustat
FibroGen
chronic kidney disease
Astellas' Anemia Drug Roxadustat Shows Non-Inferiority to Amgen's Aranesp
BioSpace
Mon, 06/8/20 - 11:36 pm
Astellas
clinical trials
roxadustat
Amgen
Aranesp
anemia
chronic kidney disease
Easing concerns, FibroGen, AstraZeneca secure FDA date for their anemia drug in broad chronic kidney disease population
Endpoints
Wed, 02/12/20 - 10:50 am
FibroGen
AstraZeneca
FDA
anemia
chronic kidney disease
roxadustat
Data From 3 Roxadustat Trials Lead Off Kidney Week Sessions Ahead of Efficacy, Safety News
Managed Markets Network
Sat, 11/9/19 - 12:12 pm
nephrology
roxadustat
AstraZeneca
FibroGen
kidney disease
FibroGen founder Thomas Neff dies suddenly as drug he championed racks up milestones
Fierce Pharma
Mon, 08/26/19 - 12:32 pm
FibroGen
Thomas Neff
Pharma CEOs
roxadustat
AstraZeneca's Kidney Drug Roxadustat Gets Second Nod in China
Yahoo/Zacks.com
Fri, 08/23/19 - 10:04 am
AstraZeneca
FibroGen
China
roxadustat
chronic kidney disease
AstraZeneca pays Sobi $95M for priority review voucher
Fierce Biotech
Thu, 08/22/19 - 11:57 am
AstraZeneca
FDA
Sobi
priority review vouchers
roxadustat

Pages